title: Eplerenone use in primary aldosteronism during pregnancy.
authors.forename: Aderville
authors.initials: A
authors.lastname: Cabassi
authors.forename: Rossana
authors.initials: R
authors.lastname: Rocco
authors.forename: Roberto
authors.initials: R
authors.lastname: Berretta
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Regolisti
authors.forename: Alberto
authors.initials: A
authors.lastname: Bacchi-Modena
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000601:surgery; D000315:Adrenalectomy; D018246:Adrenocortical Adenoma / Q000150:complications / Q000601:surgery; D000328:Adult; D000077545:Eplerenone; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy* / Q000209:etiology; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000209:etiology; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone